το θεμα ειναι οτι εχουμε να κανουμε με μια νεα ουσια και ξεφευγουμε λιγο απο τα συνηθισμενα σιγουρα ο χρονος θα δειξει τι μπορει να κανει
From the site
http://spectraldncn.com/Frequently Asked Questions:
The introduction of Spectral.F7, a new topical hair-growth booster, was met with both excitement and skepticism, which included questions about the authenticity of the astressin-B contained in it. DS Laboratories is the first biotech developer to synthesize and commercialize the astressin-B peptide for human use in a cosmetic.
Indeed, the astressin-B contained in Spectral.F7 is authentic. The DS Laboratories team of chemists worked quickly to develop it, and the company invested heavily to introduce it first. Spectral.F7 was released less than a year after publication of the peptides role in hair growth.
Below, DS Laboratories answers some frequently asked questions.
1. How does astressin-B work when applied topically?
The exact mechanism of action of many compounds is not yet known, and the establishment of efficacy standards requires further clinical testing. Even the widely used agent minoxidil, employed for 30 years now, works by a mechanism of action not yet fully elucidated. When astressin-B first appeared in the scientific literature, associated with hair regrowth in mice, DS Laboratories added the peptide to its ongoing internal program of screening topical compounds with hair enhancement potential. Preliminary results for the peptide were favorable, so the company made it available to benefit customers. DS Laboratories believes that astressin-b will prove to be a useful topical therapy for many.
2. How can DS Laboratories make this costly peptide available commercially?
DS Laboratories specializes in commercializing research compounds, precursor chemicals, and other difficult-to-source materials to formulate its dozens of unique, high-performance treatments for hair, scalp, and skin. In the case of astressin-B, the company committed sufficient resources to achieve good economies of scale in both materials and manufacturing. Early demand for Spectral.F7 has justified this investment, and the companys rapidly expanding global distribution network will enable further cost control in the future.
3. How well can astressin-B penetrate scalp, given its high molecular weight?
In several DS Laboratories products, proprietary encapsulation techniques enhance the absorption of materials deep below the surface of the skin. Spectral.F7 employs Nanosome encapsulation plus two auxiliary peptides that also facilitate absorption of astressin-B and increase its stability in solution. Even in free form (aqueous solution without penetration enhancers), trials have found that astressin-B produces results. While the exact mechanism of action behind the benefits may require more research, the mission of DS Laboratories is to bring beneficial products to consumers as soon as safety and efficacy are established.
4. Is this the same astressin-B as used in the published studies?
Yes, Spectral.F7 contains true astressin-B, which is a peptide (protein fragment) with an acetylated N-terminus, an amidated C-terminus, and a lactam bridge containing over 30 amino acids. DS Laboratories astressin-B is made to exceptionally high levels of purity.
5. How can Spectral.F7 be available already?
While many brands are planning to begin research on what may become a product some time in the future, DS Laboratories has an astressin-B topical booster on the market today. How? Because at the core of the DS Laboratories mission is to innovate, to operate at the cutting edge, and to improve quality of life for its customers.
6. What is the concentration of astressin-B in Spectral.F7?
Spectral.F7 topical treatment contains 15 parts per million or 0.015g/L of astressin-B in solution.
7. How do I store Spectral.F7?
For optimal long-term storage of Spectral.F7, keep it above 4°C (39°F) and below 26°C (79°F). The solution should never be stored below 4°C (39°F) or above 26°C (79°F).
8. What is the best way to use Spectral.F7?
While Spectral.F7 offers good efficacy as a stand-alone therapy, it is intended primarily as a booster to be used in conjunction with other modalities of treatment, such as minoxidil, finasteride, procyanidin, etc. Spectral.F7 boosts overall efficacy by exerting an additional mechanism of action on hair. Men and women newly concerned about their hair or just beginning treatment for it can use Spectral.F7 to help manage scalp problems.
9. What are the advantages of Spectral.F7 over other treatments?
Spectral.F7 is pleasant to use and uniquely free of side effects because it contains no solvents other than water. The treatment strategy works by increasing overall scalp health, so every user, regardless of duration or type of problem, can benefit.
10. What about future research involving astressin-B?
Most of the research planned for astressin-b involves systemic use as an oral or injectable medication. More treatments, developed and marketed as drugs, may appear in coming years. Spectral.F7, however, is a cosmetic treatment available today.
